Ema: “Do not administer the AstraZeneca vaccine to those with capillary permeability”

Ema: “Do not administer the AstraZeneca vaccine to those with capillary permeability”
Ema: “Do not administer the AstraZeneca vaccine to those with capillary permeability”

Brussels – EMA’s safety committee concluded that people who previously had capillary leak syndrome should not be vaccinated with AstraZeneca’s serum. The syndrome, explains Ema, is a very rare and serious condition that causes fluid loss from small blood vessels (capillaries), resulting in swelling mainly in the arms and legs, low blood pressure, thickening of the blood, and low levels of albumin in the blood.

Ema continues the analysis on reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the membrane around the heart) in a small number of people after vaccination with Covid-19 sera. Finally, Ema recommends updating information on Veklury (remdesivir) treatment to include bradycardia as an adverse reaction of unknown frequency for this medicine.

Source

Ema administer AstraZeneca vaccine capillary permeability

PREV Peugeot 308: prices announced
NEXT Quick and easy, this exceptional summer dish will conquer everyone in 10 minutes